Presolicitation
Ondansetron 4MG and 8MG
Dept of Defense · Defense Logistics Agency · Sol. SPE2D223R0007
No deadline
AI summary Beta
The Defense Logistics Agency plans to buy Ondansetron 4 mg and 8 mg tablets (including a dispersible type) under a national requirements contract. It would run one base year plus four option years and supply DoD, VA, Indian Health Service and Bureau of Prisons customers through prime vendor programs.
Watch out for
- National requirements contract. A contract that supplies several federal customers nationwide may need large volume and strong supply capacity, which is a lot for a small business.
A contract resulting from this solicitation will establish a national supply source
- Dates look inconsistent. The notice was posted in December 2023 but says the solicitation is projected for March of 2023, so the real timing is unclear.
The current projected solicitation date is March of 2023.
Read from the notice text only.
Full brief
What they want
- Supply Ondansetron HCL 4 and 8 MG tablets
- Supply Ondansetron HCL 4 and 8 MG tablets, DIS
- Serve as a national supply source for DoD, VA, Indian Health Service and Bureau of Prisons customers
- Fill orders through the DLA and VA prime vendor programs
- Contract type
- Firm-fixed price requirements contract (FAR 52.216-21), commercial item under FAR Part 12
- Period of performance
- 1 base year + 4 one-year options
- Place of performance
- Not stated
- Contract vehicle
- Orders placed through the DLA and VA prime vendor programs
- How to submit
- Solicitation to be posted on DIBBS (https://www.dibbs.bsm.dla.mil) and SAM.gov; how to submit is not stated yet
What to include when you submit
- Questions go to Christopher Newman at Christopher.Newman@dla.mil
- Set up automated notifications for solicitation changes
You must have
- Open to all sources: the acquisition is unrestricted (no set-aside)
This will be an unrestricted and fully competitive acquisition.
Not in the notice text
- Annual usage estimates (to be in the Schedule of Supplies in the solicitation)
- Evaluation method and factors
- Proposal due date
- Any manufacturer, licensing or FDA-related requirements
- Actual solicitation date
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Posted
- Dec 14, 2023
- Notice type
- Presolicitation
- Solicitation
- SPE2D223R0007
- Agency
- Dept of Defense · Defense Logistics Agency
- Office
- DLA Troop Support
- NAICS
- 325412
- Product/service code
- 6505
- Business type
- Medical & healthcare
- Contracting contact
- Christopher Newmanchristopher.newman@dla.mil2157372905
- Versions
- 7 (amended since first posted)
Full notice text from SAM.gov
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ondansetron. Procurement details follow. Ondansetron HCL 4 and 8MG Tablets and Ondansetron HCL 4 and 8 MG Tablets, DIS. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and www.SAM.gov. Interested parties should contact Christopher Newman via email: (Christopher.Newman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is March of 2023. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans an unrestricted RFP for Latanoprost eye drops for the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center.
- Imatinib TabletsThe VA Enterprise Procurement Office plans an unrestricted RFP for Imatinib Mesylate tablets to supply the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).
- Epinephrine InjectorThe Defense Logistics Agency (DLA Troop Support) is soliciting a national requirements contract for epinephrine 0.3 mg auto-injectors, to supply Department of Defense, VA, Indian…
- Prednisolone 1% Ophthalmic Solution